| Biomarker ID | 1428 |
| PMID | 24867541 |
| Year | 2014 |
| Biomarker | DAB2IP |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Reduced in lower FFBF (Freedom From Biochemical Faliure) |
| Odds Ratio/Hazard Ratio/Relative Risk | HR: 3.7 (95% CI: 1.0-13.7); p=0.055 |
| Effect on Pathways | Pathways include: Ras family activation regulation |
| Experiment | Freedom From Biochemical Failure Vs Biochemical Failure |
| Type of Biomarker | Prognostic |
| Cohort | 54 patients with high-risk prostate cancer were included. All patients were treated definitively with external beam radiation therapy using a variety of techniques |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.04 |
| Method Used | Immunohistochemistry |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |